Pelthos Therapeutics Inc. (PTHS) — Tangible Net Worth Ratio
Pelthos Therapeutics Inc. (PTHS) has a Tangible Net Worth Ratio of -1.5% as of December 2025. This metric is calculated by deducting intangible assets ($39.47 Million) from net assets ($38.88 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Pelthos Therapeutics Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pelthos Therapeutics Inc. Tangible Net Worth Ratio (2025–2025)
This chart shows how Pelthos Therapeutics Inc.'s Tangible Net Worth Ratio has changed across 1 annual periods from 2025 to 2025. As of December 2025, the ratio stands at -1.5%, reflecting net assets of $38.88 Million with intangible assets of $39.47 Million USD.
Annual Tangible Net Worth Ratio for Pelthos Therapeutics Inc. (2025–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Pelthos Therapeutics Inc. from 2025 to 2025, covering 1 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Pelthos Therapeutics Inc. market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -1.5% | $38.88 Million | $39.47 Million | $130.40 Million | — |